Jamie O'Sullivan

Dr. Jamie O'Sullivan is a Lecturer and Principal Investigator at the Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). Her research focuses on the bidirectional interactions between coagulation pathways and cancer metastasis, particularly involving von Willebrand Factor (VWF) in diseases like cancer, malaria, and inflammatory conditions. She holds a BSc in Biomedical Science from University College Cork and a PhD in Haematology from Trinity College Dublin, supported by an Irish Research Council scholarship. Notable awards include the 2018 Martin Villar Haemostasis Award and a Novartis Fellowship.

Education:

• PhD in Haematology, Trinity College Dublin (2015)
• BSc Biomedical Science, University College Cork (Ireland)
• BSc Biomedical Science, Cork Institute of Technology (Ireland)

Research Interests: Her work explores VWF's roles in cancer metastasis, thrombosis, and vascular biology. Key areas include VWF clearance pathways, endothelial-tumor interactions, and therapeutic targeting of VWF in diseases like multiple myeloma and breast cancer.

Grants & Funding: Her lab is supported by grants from Science Foundation Ireland, the Irish Research Council, and industry collaborations. Ongoing projects include studies on the VWF-ADAMTS13 axis in cancer-associated thrombosis and the role of tinzaparin in breast cancer metastasis.

Awards:

• 2018 Martin Villar Haemostasis Award
• Novartis Fellowship (2017–2019)

Labs & Teams: The O'Sullivan Lab is part of the Irish Centre for Vascular Biology, collaborating with international groups like KU Leuven University. She also leads the StAR Programme in RCSI, training future researchers in vascular biology.